Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SPHERES

Financiado

Lipid droplet hypertrophy the link between adipocyte dysfunction and cardiomet...

Lipid droplet hypertrophy the link between adipocyte dysfunction and cardiometabolic diseases The goal of SPHERES is to understand the dynamics and consequences of adipocyte hypertrophy (enlargement) through investigation of its large lipid droplet (LD). The adipocyte LD is a unique organelle specialized in storing energy... ver más

31/08/2027

UNIVERSITE TOULOUS...

10M€

Presupuesto del proyecto: 10M€

Líder del proyecto

UNIVERSITE PAUL SABATIER TOULOUSE III No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 6 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-03-18

ERC-2019-SyG: ERC Synergy Grant

I+D

Cerrada hace 6 años

0% 100% 100%

6 Participantes

UNIVERSITE TOULOUSE III - Pa...

3.54M€ | Lider

RADIADORES ORDOÑEZ, S.A.

553.02K€ | Participante

UNIVERSITE COTE DAZUR

N.D. | Participante

INSERM

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BFU2013-44229-R CARACTERIZACION DE NUEVAS RUTAS REGULADORAS DEL METABOLISMO... 266K€ Cerrado

PCIN-2016-007 METABOLISMO DE ACIDOS GRASOS-PUENTE ENTRE DIETA Y SALUD CARD... 100K€ Cerrado

PID2021-128891OB-I00 MEJORA DE LA FUNCION CARDIACA MEDIANTE EL CONOCIMIENTO DEL E... 303K€ Cerrado

CHANCE Structure guided inhibition of IDOL to treat atherosclerosis... 150K€ Cerrado

PCIN-2016-084 METABOLISMO DE ACIDOS GRASOS INTERCONEXION ENTRE DIETA Y R... 100K€ Cerrado

BFU2008-00345 ACUMULACION INTRACELULAR DE LIPIDOS: PAPEL DE CAVEOLINA-1, M... 206K€ Cerrado

Duración del proyecto: 89 meses Fecha Inicio: 2020-03-18
Fecha Fin: 2027-08-31

Líder del proyecto

UNIVERSITE PAUL SABATIER TOULOUSE III No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 10M€

Descripción del proyecto The goal of SPHERES is to understand the dynamics and consequences of adipocyte hypertrophy (enlargement) through investigation of its large lipid droplet (LD). The adipocyte LD is a unique organelle specialized in storing energy in triglycerides (TGs). Its surface is composed of a phospholipid monolayer and specific LD-associated proteins (such as perilipins, CIDEs and lipases), which jointly regulate LD stability and TG turnover. Adipocyte hypertrophy due to an increase in LD size may, irrespective of body fat mass, cause a wide range of pathological conditions, notably cardiometabolic diseases. SPHERES PIs (Langin, Rydén, Antonny) postulate that disturbances in the interactions between LD proteins and LD lipid composition lead to adipocyte hypertrophy and its deleterious consequences. We have identified three fundamental unanswered questions: what determines the unique structure and dynamics of large LD; why does increased LD size alter the functional phenotype of the adipocyte; which factors cause inter-individual variations in LD size. To address these questions, SPHERES gathers expertise in clinical and cellular studies on human adipocytes, in/ex vivo investigations in mouse models, and biophysical analyses of LDs. At the core of this application is the development of beyond-state-of-the-art models and methods (spheroid cultures, native large LD preparation and reconstitution, proximity labelling of LD proteins, gene editing in cell and mouse models, and advanced LD imaging), only achievable through joint integrated effort of the PIs and co-workers. Spanning from molecular, cellular to the whole-body level, SPHERES will link new knowledge on the formation and maintenance of large adipocyte LDs to the deleterious impact of adipocyte hypertrophy. Altogether, SPHERES has a strong potential to discover novel pathogenic mechanisms, leading to a better understanding of highly prevalent diseases and identification of therapeutic strategies targeting adipocytes.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores